Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), Application (Pain Relief, Anesthesia), Route Of Administration, Distribution Channel, Region, & Segment Forecasts, 2023

The global opioid market size is expected to reach USD 25.3 billion by 2030, registering a CAGR of 1.4% during the forecast period, according to a new report by Grand View Research, Inc.. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. For instance, in June 2021, the U.S. FDA approved nalmefene hydrochloride injection developed by Purdue Pharma L.P.Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose. The expected approval of a product is anticipated to drive the growth.

Moreover, in June 2021, morphine sulfate tablets and morphine sulfate oral solution were approved by FDA for the management of severe pain in pediatric and adult patients for whom other treatment options were less. Thus, approval of new opioid and their launch is also expected to drive the growth.

Growing use of the opioids for the management of post-operative pain, caused due to the surgeries, is expected to drive the market growth. According to the Canadian Centre on Substance Use and Addiction, in 2020, approximately 11.8% of all the population used opioid analgesics for the management of symptoms. Tramadol and codeine are frequently dispensed for the postoperative opioid prescription in surgeries within the region.

Emergence of non-addictive alternative products to opioids for the pain-management leads to decline in the growth of opioid market. According to American Society of Anesthesiologists, there are several non-opioid medicines that are available over the counter steroids and NSAIDs such as aspirin, ibuprofen, and acetaminophen among others. Furthermore, wide availability and low cost associated with these drugs contribute to increase in demand for such products during the forecast period. For instance, aspirin cost USD 10 for a pack of 30 tablets.

In addition, in February 2022, the U.S. FDA has undertaken an initiative to encourage the development of non-addictive analgesics alternatives to opioids under its HHS overdose prevention strategy for the management of acute and chronic pain. The regulatory agency issued recommendation to pharmaceutical companies to develop non-opioid analgesic products. Such initiatives may restrain the overall growth of the opioids market.

Opioids Market Report Highlights:

By product, ER/long acting opioids segment held the largest market share in 2022 due to the increasing approval and launch of the novel ER/ long-acting opioids. For instance, in June 2021, the U.S. FDA accepted a review application for a new drug application for buprenorphine (Brixadi) for the pain management. Buprenorphine is an extended release long-acting opioid drug
By application, pain relief segment dominated the opioids market in 2022 and is expected to witness significant market growth owing to increasing prevalence of the patients with chronic pain. According to the Canadian Institute for Health Information and Canadian Pain Task Force report of 2021, 1 in every 5 adults in Canada suffers from chronic pain
By route of administration, injectable segment dominated the opioids market in 2022. This dominance can be attributed to wide availability of products used for the treatment of chronic pain and increased procedures requiring anesthesia
By distribution channel, retail pharmacy dominated the opioids market in 2022. The availability of retail pharmacies with high dispensing rate of opioid driving segment growth
Asia pacific is expected to be the fastest growing region during the forecast period. The growth of the region can be attributed to increasing geriatric population which are susceptible to the chronic pain.

Product Code: GVR-2-68038-131-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Route of administration
- 1.1.4. Distribution channel
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Route of administration outlook
- 2.2.4. Distribution channel outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Opioids Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Opioids Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Opioids: Product Estimates & Trend Analysis

4.1. Opioids Market: Key Takeaways
4.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
4.3. IR/Short Acting Opioids
- 4.3.1. IR/ Short Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. ER/Long Acting Opioids
- 4.4.1. ER/ Long Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Opioids: Application Estimates & Trend Analysis

5.1. Opioids Market: Key Takeaways
5.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Pain Relief
- 5.3.1. Pain relief market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Anesthesia
- 5.4.1. Anesthesia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cough Suppression
- 5.5.1. Cough suppression market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Diarrhea Suppression
- 5.6.1. Diarrhea suppression market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. De-addiction
- 5.7.1. De-addiction market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis

6.1. Opioids Market: Key Takeaways
6.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
- 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Injectable
- 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
- 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis

7.1. Opioids Market: Key Takeaways
7.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospital Pharmacy
- 7.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Retail Pharmacy
- 7.4.1. Retail Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
- 7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Opioids Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Opioids Market by Region: Key Takeaways
8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. Germany
  - 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.3. France
  - 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.4. Italy
  - 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.5. Spain
  - 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.6. Sweden
  - 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.7. Norway
  - 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.8. Denmark
  - 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.2. China
  - 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.3. India
  - 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.4. Australia
  - 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.5. Thailand
  - 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.6. South Korea
  - 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. Mexico
  - 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
- 8.7.1. Saudi Arabia
  - 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.2. South Africa
  - 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
  - 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
- 9.2.1. Purdue Pharma L.P.
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Johnson & Johnson Services, Inc.
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Hikma Pharmaceuticals PLC
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. Pfizer Inc.
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. AbbVie Inc.
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Sanofi
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Sun Pharmaceutical Industries Ltd
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. Grunenthal
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Merck & Co., Inc.
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives

Product Code: GVR-2-68038-131-3

List of Tables

Table 1 List of Abbreviation
Table 2 North America opioids market, by product, 2018 - 2030 (USD Million)
Table 3 North America opioids market, by application, 2018 - 2030 (USD Million)
Table 4 North America opioids market, by route of administration, (USD Million) 2018 - 2030
Table 5 North America opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 North America opioids market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. opioids market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. opioids market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. opioids market, by route of administration, (USD Million) 2018 - 2030
Table 10 U.S. opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada opioids market, by product, 2018 - 2030 (USD Million)
Table 12 Canada opioids market, by application, 2018 - 2030 (USD Million)
Table 13 Canada opioids market, by route of administration, (USD Million) 2018 - 2030
Table 14 Canada opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe opioids market, by product, 2018 - 2030 (USD Million)
Table 16 Europe opioids market, by application, 2018 - 2030 (USD Million)
Table 17 Europe opioids market, by route of administration, (USD Million) 2018 - 2030
Table 18 Europe opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Europe opioids market, by region, 2018 - 2030 (USD Million)
Table 20 Germany opioids market, by product, 2018 - 2030 (USD Million)
Table 21 Germany opioids market, by application, 2018 - 2030 (USD Million)
Table 22 Germany opioids market, by route of administration, (USD Million) 2018 - 2030
Table 23 Germany opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 UK opioids market, by product, 2018 - 2030 (USD Million)
Table 25 UK opioids market, by application, 2018 - 2030 (USD Million)
Table 26 UK opioids market, by route of administration, (USD Million) 2018 - 2030
Table 27 UK opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 France opioids market, by product, 2018 - 2030 (USD Million)
Table 29 France opioids market, by application, 2018 - 2030 (USD Million)
Table 30 France opioids market, by route of administration, (USD Million) 2018 - 2030
Table 31 France opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Italy opioids market, by product, 2018 - 2030 (USD Million)
Table 33 Italy opioids market, by application, 2018 - 2030 (USD Million)
Table 34 Italy opioids market, by route of administration, (USD Million) 2018 - 2030
Table 35 Italy opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Spain opioids market, by product, 2018 - 2030 (USD Million)
Table 37 Spain opioids market, by application, 2018 - 2030 (USD Million)
Table 38 Spain opioids market, by route of administration, (USD Million) 2018 - 2030
Table 39 Spain opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Denmark opioids market, by product, 2018 - 2030 (USD Million)
Table 41 Denmark opioids market, by application, 2018 - 2030 (USD Million)
Table 42 Denmark opioids market, by route of administration, (USD Million) 2018 - 2030
Table 43 Denmark opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 Sweden opioids market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden opioids market, by application, 2018 - 2030 (USD Million)
Table 46 Sweden opioids market, by route of administration, (USD Million) 2018 - 2030
Table 47 Sweden opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Norway opioids market, by product, 2018 - 2030 (USD Million)
Table 49 Norway opioids market, by application, 2018 - 2030 (USD Million)
Table 50 Norway opioids market, by route of administration, (USD Million) 2018 - 2030
Table 51 Norway opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Asia Pacific opioids market, by product, 2018 - 2030 (USD Million)
Table 53 Asia Pacific opioids market, by application, 2018 - 2030 (USD Million)
Table 54 Asia Pacific opioids market, by route of administration, (USD Million) 2018 - 2030
Table 55 Asia Pacific opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Asia Pacific opioids market, by region, 2018 - 2030 (USD Million)
Table 57 Japan opioids market, by product, 2018 - 2030 (USD Million)
Table 58 Japan opioids market, by application, 2018 - 2030 (USD Million)
Table 59 Japan opioids market, by route of administration, (USD Million) 2018 - 2030
Table 60 Japan opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 China opioids market, by product, 2018 - 2030 (USD Million)
Table 62 China opioids market, by application, 2018 - 2030 (USD Million)
Table 63 China opioids market, by route of administration, (USD Million) 2018 - 2030
Table 64 China opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 India opioids market, by product, 2018 - 2030 (USD Million)
Table 66 India opioids market, by application, 2018 - 2030 (USD Million)
Table 67 India opioids market, by route of administration, (USD Million) 2018 - 2030
Table 68 India opioids market, by distribution channel, (USD Million) 2018 - 2030
Table 69 Australia opioids market, by product, 2018 - 2030 (USD Million)
Table 70 Australia opioids market, by application, 2018 - 2030 (USD Million)
Table 71 Australia opioids market, by route of administration, (USD Million) 2018 - 2030
Table 72 Australia opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 73 Thailand opioids market, by product, 2018 - 2030 (USD Million)
Table 74 Thailand opioids market, by application, 2018 - 2030 (USD Million)
Table 75 Thailand opioids market, by route of administration, (USD Million) 2018 - 2030
Table 76 Thailand opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 77 South Korea opioids market, by product, 2018 - 2030 (USD Million)
Table 78 South Korea opioids market, by application, 2018 - 2030 (USD Million)
Table 79 South Korea opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 80 South Korea opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 Latin America opioids market, by product, 2018 - 2030 (USD Million)
Table 82 Latin America opioids market, by application, 2018 - 2030 (USD Million)
Table 83 Latin America opioids market, by route of administration, (USD Million) 2018 - 2030
Table 84 Latin America opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 85 Latin America opioids market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil opioids market, by product, 2018 - 2030 (USD Million)
Table 87 Brazil opioids market, by application, 2018 - 2030 (USD Million)
Table 88 Brazil opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 89 Brazil opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 90 Mexico opioids market, by product, 2018 - 2030 (USD Million)
Table 91 Mexico opioids market, by application, 2018 - 2030 (USD Million)
Table 92 Mexico opioids market, by route of administration, (USD Million) 2018 - 2030
Table 93 Mexico opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 94 Argentina opioids market, by product, 2018 - 2030 (USD Million)
Table 95 Argentina opioids market, by application, 2018 - 2030 (USD Million)
Table 96 Argentina opioids market, by route of administration, (USD Million) 2018 - 2030
Table 97 Argentina opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa opioids market, by product, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa opioids market, by application, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa opioids market, by route of administration, (USD Million) 2018 - 2030
Table 101 Middle East and Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa opioids market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa opioids market, by product, 2018 - 2030 (USD Million)
Table 104 South Africa opioids market, by application, 2018 - 2030 (USD Million)
Table 105 South Africa opioids market, by route of administration, (USD Million) 2018 - 2030
Table 106 South Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia opioids market, by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia opioids market, by application, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia opioids market, by route of administration, (USD Million) 2018 - 2030
Table 110 Saudi Arabia opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 UAE opioids market, by product, 2018 - 2030 (USD Million)
Table 112 UAE opioids market, by application, 2018 - 2030 (USD Million)
Table 113 UAE opioids market, by route of administration, (USD Million) 2018 - 2030
Table 114 UAE opioids market, by distribution channel, 2018 - 2030 (USD Million)
Table 115 Kuwait opioids market, by product, 2018 - 2030 (USD Million)
Table 116 Kuwait opioids market, by application, 2018 - 2030 (USD Million)
Table 117 Kuwait opioids market, by route of administration, 2018 - 2030 (USD Million)
Table 118 Kuwait opioids market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Opioids: Market outlook
Fig. 9 Opioids: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Opioids market driver impact
Fig. 15 Opioids market restraint impact
Fig. 16 Opioids market strategic initiatives analysis
Fig. 17 Opioids market: Product movement analysis
Fig. 18 Opioids market: Product outlook and key takeaways
Fig. 19 IR/Short acting opioids market estimates and forecasts, 2018 - 2030
Fig. 20 ER/Long acting opioids market estimates and forecasts, 2018 - 2030
Fig. 21 Opioids market: Application movement analysis
Fig. 22 Opioids market: Application outlook and key takeaways
Fig. 23 Pain relief market estimates and forecasts, 2018 - 2030
Fig. 24 Anesthesia market estimates and forecasts, 2018 - 2030
Fig. 25 Cough suppression market estimates and forecasts, 2018 - 2030
Fig. 26 Diarrhea suppression market estimates and forecasts, 2018 - 2030
Fig. 27 De-addiction market estimates and forecasts, 2018 - 2030
Fig. 28 Opioids market: Route of administration movement analysis
Fig. 29 Opioids market: Route of administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Injectable market estimates and forecasts, 2018 - 2030
Fig. 32 Others market estimates and forecasts, 2018 - 2030
Fig. 33 Opioids market: Distribution channel movement analysis
Fig. 34 Opioids market: Distribution channel outlook and key takeaways
Fig. 35 Hospital pharmacy market estimates and forecasts, 2018 - 2030
Fig. 36 Retail pharmacy market estimates and forecasts, 2018 - 2030
Fig. 37 Others market estimates and forecasts, 2018 - 2030
Fig. 38 Global opioids market: Regional movement analysis
Fig. 39 Global opioids market: Regional outlook and key takeaways
Fig. 40 North America market estimates and forecasts, 2018 - 2030
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
Fig. 42 Canada market estimates and forecasts, 2018 - 2030
Fig. 43 Europe market estimates and forecasts, 2018 - 2030
Fig. 44 UK market estimates and forecasts, 2018 - 2030
Fig. 45 Germany market estimates and forecasts, 2018 - 2030
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain market estimates and forecasts, 2018 - 2030
Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
Fig. 51 Norway market estimates and forecasts, 2018 - 2030
Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 53 Japan market estimates and forecasts, 2018 - 2030
Fig. 54 China market estimates and forecasts, 2018 - 2030
Fig. 55 India market estimates and forecasts, 2018 - 2030
Fig. 56 Australia market estimates and forecasts, 2018 - 2030
Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 66 UAE market estimates and forecasts, 2018 - 2030
Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), Application (Pain Relief, Anesthesia), Route Of Administration, Distribution Channel, Region, & Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Opioids Market Growth & Trends:

Opioids Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Opioids Market Variables, Trends & Scope

Chapter 4. Opioids: Product Estimates & Trend Analysis

Chapter 5. Opioids: Application Estimates & Trend Analysis

Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis

Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis

Chapter 8. Opioids Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures